Abstract
Statins (inhibitors of HMG-ConA reductase) are widely used as cholesterol-lowering agents and have beneficial action in patients with complications of atherosclerosis (coronary disease). In addition, recent data indicate that they can also modulate a variety of other biological processes inhibiting neointimal proliferation, reducing inflammation and stimulating osteogenesis (1 2 3). Moreover, our preliminary studies point to the role of statins as potential immunosuppressive agents (4). In this report, we confum and extend those initial observations.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Vaughan, C.J., Murphy, M.B. and Buckley, B.M. 2000, Statins do more than just lower cholesterol. Lancet 348:1079.
Senior, K. 2000, The hidden potential for statins. Lancet 356:1905.
Rogers, M.J. 2000, Statins: lower lipid and better bones? Nature Medicine 6:21.
Górski, A., Orlowska A., Nowaczyk M., et al. 1999, Statins inhibit T-cell interactions with elastin. Transplant.Proc. 31:828–829.
Górski, A., Grieb, P., Korczak-Kowalska, G., et al. 1993, Cladribine (2-chlorodeoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro. Immunopharmacology 26:197–202.
Imiela, J., Korczak-Kowalska, G., Malecki R., et al. 1993, Immunomodulatory action of human recombinant erythropoietin in man. Immunology Letters 35:271–276.
Górski, A., W4sik, M., Stepieñ-Sopniewska, B. et al. 1991, Heparin and platelet interactions influence alloantigen-induced proliferative responses of human T lymphocytes and immunoglobulin synthesis in vitro. Immunology Letters 28:161–166.
Ito, M., Watanabe, M., Kamiya H., and Sakurai, M. 1997, Changes in intracellular cytokine levels in lymphocytes induced by measles virus. Clin.Immun.Immunopathol. 83:281–286.
Jo, E.K., Kim, J.K. and Lim, J.H. 2000, Dysregulated production of interferon-gamma, interleukin-4 and interleukin-6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis. Scand.J.Immunol. 51:209–217.
Górski, A., Castronovo, V., Stepieñ-Sopniewska, B. et al. 1994, Depressed immune surveillance against cancer: role of deficient T cell:extracellular matrix interactions. Cell Adhesion Com. 2:225–233.
Korczak-Kowalska, G., Nowaczyk, M., Stepiefi-Sopniewska, B. et al. 1997, T-cell interactions with the extracellular matrix proteins and endothelium in chronic renal allograft rejection. Transplant.Proc.29:1057–1059.
Rokosz, A., Meisel-Mikolajczyk, F., Malchar, C., Nowaczyk, M., Górski, A. 1999, Adhesion molecule expression stimulated by B.thetaiotaomicron cell-surface antigens. Arch.Immun. Ther. Exp. 47:169–175.
Kwak, B., Muthaupt, F., Myit, S. and Mach, F. 2000, Statins as a newly recognized type of immunomodulator. Nature Medicine 6:1399–1402.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Górski, A. et al. (2001). Statins as immunomodulatory drugs. In: Mackiewicz, A., Kurpisz, M., Żeromski, J. (eds) Progress in Basic and Clinical Immunology. Advances in Experimental Medicine and Biology, vol 495. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0685-0_39
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0685-0_39
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5194-8
Online ISBN: 978-1-4615-0685-0
eBook Packages: Springer Book Archive